A first-time mother was plunged into a terrifying ordeal after a standard pregnancy screening unexpectedly revealed she had a high probability of cancer. Dolly Chhabria, aged 37, faced the heart-wrenching prospect that she might not live to see her unborn daughter grow up, following the shocking discovery during what should have been a joyful prenatal check.
The Routine Scan That Changed Everything
In August 2023, Dolly and her husband Kumar Ekansh, also 37, celebrated the news that they were expecting their first child. The following month, Dolly underwent Non-Invasive Prenatal Testing (NIPT), a common blood test that analyses foetal DNA to assess chromosomal risks. To her devastation, the results indicated a fifty percent chance that Dolly herself had cancer.
A subsequent full-body MRI scan identified abnormal masses above her heart and near her collarbone. A biopsy conducted on December 1, 2023, confirmed the diagnosis: Dolly was indeed battling a serious malignancy. However, due to her pregnancy, medical professionals advised that treatment could not commence until after she gave birth, leaving her in a state of anxious limbo.
Agonising Wait and Birth of Daughter Edha
Dolly described the period as one of profound fear and uncertainty. "I was supposed to be glowing and preparing a nursery, but instead I was living in terrifying limbo," she recalled. "I was thinking that I might not be around to watch the baby I am carrying grow up. I thought that only one of us would survive and if it came to a choice, I would have saved my baby."
To manage the cancer's progression during pregnancy, Dolly received bridge therapy—a temporary stabilising treatment. She welcomed her daughter, Edha, at 37 weeks on March 25, 2024; the baby weighed 2.5 kilograms. Merely a week and a half later, Dolly began intensive chemotherapy, marking the start of a gruelling medical journey.
Diagnosis of Rare Gray Zone Lymphoma
Further testing ultimately identified Dolly's condition as Gray Zone Lymphoma, an exceptionally rare and aggressive form of B-cell lymphoma. This diagnosis brought additional challenges due to the lack of standardised treatment protocols and large-scale clinical trials for such an uncommon disease. In October 2024, scans revealed the cancer had spread to her neck, intensifying her fears about survival.
Dolly expressed her distress: "It's so uncommon that there are no clear roadmap to survival. Again, I started worrying whether or not I would be there to see my child grow up."
Intensive Treatment and Path to Remission
Her treatment regimen was arduous and multifaceted:
- In November 2024, she commenced three months of immunotherapy, which showed promising initial results.
- This was followed by a stem cell transplant, a procedure to replace damaged blood-forming cells with healthy ones.
- She concurrently underwent high-dose chemotherapy to combat the aggressive lymphoma.
By April 30, 2025, a scan delivered the welcome news that Dolly was in remission. However, the treatments exacted a heavy physical toll. "The treatments saved my life, but they've taken so much," she noted. "I've lost over 45 pounds and significant muscle mass. My heart function has declined. My thyroid no longer works properly."
Ongoing Monitoring and Recovery Efforts
Dolly, a stay-at-home mother from Seattle, Washington, USA, now undergoes CT scans every three months to monitor her health vigilantly. She is working with specialists in integrative medicine to rebuild her immune system and overall physical strength, focusing on maintaining her cancer-free status.
To assist with the substantial medical expenses incurred during her treatment, Dolly has established a GoFundMe campaign. Her story underscores the unpredictable nature of medical diagnoses and the resilience required to face life-altering health crises, especially when intertwined with the profound journey of motherhood.
